With Trial Complete, Saegis Pharmaceuticals, Inc. Eyes Series D In 2006
12/30/2005 11:11:04 AM
More...
|
Saegis Pharmaceuticals, Inc. Completes Phase IIa Clinical Study Of SGS518
12/15/2005 11:29:30 AM
More...
|
Saegis Pharmaceuticals, Inc. Completes Phase I Clinical Study Of SGS518
10/19/2005 5:13:09 PM
More...
|
Saegis Pharmaceuticals, Inc. Initiates Phase II Clinical Trial Of SGS742 In Adult ADHD
10/19/2005 5:13:05 PM
More...
|
Saegis Pharmaceuticals, Inc. Appoints Ann Neale Vice President Of Clinical Operations
10/19/2005 5:12:28 PM
More...
|
Saegis Pharmaceuticals Names Jack M. Anthony Senior Vice President Of Business Development
10/19/2005 5:11:32 PM
More...
|
Saegis Pharmaceuticals Begins Phase II Clinical Trial Of SGS742 For Alzheimer's Disease
10/19/2005 5:11:10 PM
More...
|
Saegis Pharmaceuticals Announces Lead Product Candidate SGS742 Improves Cognition In Patients With Mild Cognitive Impairment; Mixed Results
10/19/2005 5:11:04 PM
More...
|
Saegis Pharmaceuticals Completes $30 Million Private Financing; Funding Supports Ongoing Clinical Development Of Novel Therapies For Alzheimer's Disease And Schizophrenia
10/19/2005 5:10:46 PM
More...
|
Saegis Pharmaceuticals, Inc. Receives $3.8 Million From The Stanley Medical Research Institute
10/19/2005 5:10:15 PM
More...
|
|